Correlation Between Biofil Chemicals and Consolidated Construction

Can any of the company-specific risk be diversified away by investing in both Biofil Chemicals and Consolidated Construction at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofil Chemicals and Consolidated Construction into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biofil Chemicals Pharmaceuticals and Consolidated Construction Consortium, you can compare the effects of market volatilities on Biofil Chemicals and Consolidated Construction and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofil Chemicals with a short position of Consolidated Construction. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofil Chemicals and Consolidated Construction.

Diversification Opportunities for Biofil Chemicals and Consolidated Construction

0.62

Correlation Coefficient

Biofil Chemicals  Consolidated Construction

Poor diversification

The 3 months correlation between Biofil and Consolidated is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Biofil Chemicals Pharmaceutica and Consolidated Construction Cons in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Consolidated Construction and Biofil Chemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofil Chemicals Pharmaceuticals are associated (or correlated) with Consolidated Construction. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Consolidated Construction has no effect on the direction of Biofil Chemicals i.e., Biofil Chemicals and Consolidated Construction go up and down completely randomly.

Pair Corralation between Biofil Chemicals and Consolidated Construction

Assuming the 90 days trading horizon Biofil Chemicals is expected to generate 14.48 times less return on investment than Consolidated Construction. In addition to that, Biofil Chemicals is 1.12 times more volatile than Consolidated Construction Consortium. It trades about 0.01 of its total potential returns per unit of risk. Consolidated Construction Consortium is currently generating about 0.23 per unit of volatility. If you would invest  1,144  in Consolidated Construction Consortium on September 3, 2024 and sell it today you would earn a total of  751.00  from holding Consolidated Construction Consortium or generate 65.65% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Biofil Chemicals Pharmaceutica  vs.  Consolidated Construction Cons

Biofil Chemicals Pha

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Biofil Chemicals Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical indicators, Biofil Chemicals is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Consolidated Construction

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Consolidated Construction Consortium are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Consolidated Construction unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Biofil Chemicals and Consolidated Construction

The main advantage of trading using opposite Biofil Chemicals and Consolidated Construction positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofil Chemicals position performs unexpectedly, Consolidated Construction can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Consolidated Construction will offset losses from the drop in Consolidated Construction's long position.

The idea behind Biofil Chemicals Pharmaceuticals and Consolidated Construction Consortium pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.